Skip to main content
. 2018 Jan 19;9(13):11126–11144. doi: 10.18632/oncotarget.24277

Figure 5. Analysis of Sema4D in plasma of HNC patients.

Figure 5

(A) ELISA assay of Sema4D in plasma of HNSCC patients compared to HD (p<0.0001), RA and Asthma patients. (B) Sema4D level in several stages of HNSCC. HD; Healthy donors, HNSCC; Head and Neck squamous cell carcinoma, RA; Rheumatoid arthritis, ATH; Asthma patients, N/A; stage information not available.